Optional clinician consults available separately when appropriate
A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta-4 in healthy volunteers
5 mg vial + 2 mL BAC water: Concentration = 2,500 mcg/mL 250 mcg dose = 10 units (0.1 mL) on a 100-unit insulin syringe 500 mcg dose = 20 units (0.2 mL) on a 100-unit insulin syringe Doses per vial: 20 doses at 250 mcg, or 10 doses at 500 mcg Supplies Needed (8-Week Cycle at 250 mcg/day) 3 vials BPC-157 (5 mg each) provides 60 doses, covers 56 days with margin 3 vials bacteriostatic water (30 mL each) 60 insulin syringes (2931 gauge, 100-unit) Alcohol prep pads Administration Injection Technique BPC-157 goes subcutaneous (SubQ)
GHK-Cu (copper peptide) for skin GHK-Cu (glycyl-L-histidyl-L-lysine-copper) is a copper peptide studied for collagen support, antioxidant effects and wound healing
indica -inoculated plants due to an activation of GSH-dependent antioxidative pathways (Waller et al., 2005
Accelerated Injury Recovery Athletes and active individuals love peptide therapy because it speeds up the recovery of: Tendons Ligaments Muscles Joints It achieves this by stimulating angiogenesis (the formation of new blood vessels), improving circulation to damaged tissues, and promoting cell regeneration